ABVC BioPharma, Inc. (ABVC)
0.8444
-0.08
(-8.22%)
USD |
NASDAQ |
Aug 24, 16:00
0.8444
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -8.87K% |
| September 30, 2024 | 72.59% |
| June 30, 2024 | 2.22% |
| March 31, 2024 | -8.47K% |
| December 31, 2023 | -6.57K% |
| September 30, 2023 | -133.3% |
| June 30, 2023 | -1.10K% |
| March 31, 2023 | 47.93% |
| December 31, 2022 | 53.84% |
| September 30, 2022 | 59.34% |
| June 30, 2022 | 95.56% |
| March 31, 2022 | 71.60% |
| September 30, 2021 | 96.77% |
| June 30, 2021 | 88.85% |
| March 31, 2021 | 98.40% |
| December 31, 2020 | 86.01% |
| September 30, 2020 | 84.95% |
| June 30, 2020 | 93.55% |
| March 31, 2020 | 80.84% |
| December 31, 2019 | 86.30% |
| September 30, 2019 | 91.40% |
| June 30, 2019 | 84.83% |
| March 31, 2019 | 92.74% |
| December 31, 2018 | -6.33K% |
| September 30, 2018 | -1.49K% |
| Date | Value |
|---|---|
| June 30, 2018 | -321.9% |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | 81.82% |
| June 30, 2015 | |
| March 31, 2015 | 86.96% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | 0.00% |
| December 31, 2012 | 0.00% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 65.15% |
| Perspective Therapeutics, Inc. | -1.31K% |
| MiMedx Group, Inc. | 68.50% |
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.92% |
| Return on Assets | -38.92% |
| Return on Invested Capital | -49.66% |
| Return on Net Operating Assets | -55.09% |